A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin

NCT00368563 | Completed Phase 2

• 1 other identifier: PEN.1010.02
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

To evaluate the ability of 2 Helioblock SX Cream formulations to moisturize skin using capacitance and transepidermal water loss methodology

Conditions

Dry Skin

Interventions

Helioblock SX DRUG

Eligibility Criteria

• Age: 18 Years - 55 Years
• Sex: all
• Age Groups: Adult (18-64)

You may qualify if:

• Healthy,male or female subjects 18 years to 55 years of age, with a minimum Stanfield score at baseline of "2" at the forearm sites intended to be assessed in the study
• Female subjects of childbearing potential using a reliable form of contraception during the course of the study(oral contraceptive pill, intrauterine device, bilateral tubal ligation, abstinence, or other reliable forms at the discretion of the Investigator.) or of non childbearing potential(i.e.,post-menopausal(one year without menstrual period), hysterectomy or bilateral ovariectomy)
• Subjects who have read, understood and signed an informed consent
• Subjects who are willing and capable of cooperating to the extent and degree required by the protocol
• Absence of any visible skin diseases which might be confused with a skin reaction from the test material

You may not qualify if:

• Subjects with a condition, or in a situation, which in the Investigator's or Sub-Investigator's opinion, may suggest a significant hazard for the subject, may confound the study results, or may interfere with the subject's participation in the study.
• Subjects with known sensitivities to any of the study preparations or to other skin care products
• Subjects who have participated in a clinical research study, including consumer products studies, within the last 30 days prior to enrollment
• Subjects who are currently receiving medication(prescription or OTC) that in the opinion of the Investigator may interfere with the evaluations made in this study (e.g.vasoactive substances)
• Pregnant or nursing females or women who are planning to get pregnant during the study

Sponsors & Collaborators

• Loreal USA: lead

Study Sites (1)

Hill Top Research

Scottsdale, Arizona, 85251, United States

Location

Study Officials

• Linda Oddo, B.S.

  Hill Top Research

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: RANDOMIZED
• Masking: SINGLE
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY

Study Record Dates

• First Submitted: August 23, 2006
• First Posted: August 24, 2006
• Study Start: August 1, 2006
• Primary Completion: October 1, 2006
• Study Completion: October 1, 2006
• Last Updated: February 11, 2009

Record last verified: 2009-02

Locations

US (1)